Nangkuang Pharmaceutical Co., Ltd., which just celebrated the 50th anniversary, is the largest R&D based manufacturer of parenteral injections and LVP infusions in Taiwan. To achieve its corporate vision of becoming the largest professional manufacturer of acute and critical medicines, Nangkuang has invested more than 2 billion Taiwan dollars in recent years to acquire production lines (Isolators) of prefilled syringes, DEHP free LVPS, and anti-cancer drugs (liquid injections and lyophilized powder injections). According to the plan, these productions lines will be completed successively before the end of this year. After passing the certifications of Europe, USA, Japan, and other advanced countries, products will be commercialized and marketed domestically and globally. Technologies complying PIC/S GMP, absolute differentiation in product design, multinational marketing network, and integrated customized services have been the key concepts of product development of Nangkuang. Nangkuang is fully confident in seeking out a blue sky among the highly competitive red ocean, so as to bring brand new vitality to Taiwan’s pharmaceutical and biotechnology industry and accomplish the pride of Taiwan in the biotechnology field.